Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism XPO1 inhibitors(Exportin-1 protein inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC16H16F3N3O3 |
InChIKeyNLNGWFLRRRYNIL-PLNGDYQASA-N |
CAS Registry1333151-73-7 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Stomach Cancer | Preclinical | United States | 28 Sep 2019 | |
| Virus Diseases | Preclinical | United States | 10 Nov 2016 | |
| Prostatic Cancer | Preclinical | United States | 01 Dec 2015 | |
| Prostatic Cancer | Preclinical | Italy | 01 Dec 2015 | |
| Pancreatic Cancer | Preclinical | United States | 23 Oct 2012 | |
| Pancreatic Cancer | Preclinical | United States | 23 Oct 2012 |





